Regulatory Science on Novel Coronavirus Disease ** *** **** *****
Japanese Journal of Risk AnalysisVol
; 30(4):1-6, 2021.
Article
in Japanese
| J-STAGE | ID: covidwho-1200354
ABSTRACT
At the 2020 annual meeting of The Society of Risk Analysis Japan, we hosted a special session focusing on novel coronavirus disease (COVID-19) as an emerging risk. In the context of the COVID-19 pandemic, the regulatory science perspective is very important as countermeasures have to be decided in a very limited time and without sufficient scientific knowledge. The objective of the session was to discuss the contribution of risk science to countermeasures against COVID-19. The topics were as follows (1) science and policy under the risk governance;(2) risk assessment at mass gathering events;(3) regulatory science of the infection risk management and the regulatory framework issue;(4) comparison of mortality risk and economic impact.
Full text:
Available
Collection:
Databases of international organizations
Database:
J-STAGE
Language:
Japanese
Journal:
Japanese Journal of Risk AnalysisVol
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS